SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
- 19 September 2022
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 54 (4) , 587-592
Abstract
Objective Due to the coronavirus disease 2019 (COVID-19) pandemic, a significant increase has been observed in patients diagnosed with pulmonary embolism (PE) in our clinic. In addition to COVID-19-related PE, the increase in the number of patients with unprovoked or idiopathic PE was also noteworthy. Although it is not surprising that PE due to immobilization was observed in elderly patients and patients with comorbidities at risk for PE during the pandemic, it is important to investigate the increase in the number of unprovoked PE. Thus, we aimed to show that a previous COVID-19 infection may be a risk factor in these patients by examining the presence of severe acute respiratory syndrome-causing coronavirus (SARS-CoV-2) antibodies in patients diagnosed with unprovoked PE. Materials and methods The participants of the study consisted of 45 consecutive patients who were diagnosed with PE in our clinic, had no risk factors for PE, were considered unprovoked (idiopathic) PE, and had no history of COVID-19. SARS-CoV-2 antibody titers were measured in the serum samples of the patients for detecting immunity as a result of encountering COVID-19. Results Of the 45 patients diagnosed with PE, 24 (53.3%) patients were diagnosed with computed tomography pulmonary angiogram (CTPA), and 21 (46.7%) patients were diagnosed with perfusion single-photon emission computed tomography (Q-SPECT/CT). Immunity acquired after encountering COVID-19 was checked with the NCP kit, which revealed positive results in 9 (20%) patients. Conclusion It should be kept in mind that some of the patients diagnosed with idiopathic PE during the pandemic may have embolism due to asymptomatic COVID-19. In addition, it is now known that COVID-19 also creates a tendency toward thrombosis in asymptomatic patients.Keywords
This publication has 22 references indexed in Scilit:
- High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumoniaClinical Microbiology and Infection, 2020
- COVID‐19 pneumonia with back pain: Presentation of an acute pulmonary embolism associated with novel coronavirus infection in an outpatient settingClinical Case Reports, 2020
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Recognition of unprovoked (idiopathic) pulmonary embolism–Prospective observational studyRespiratory Medicine, 2018
- Clinical Presentation of Acute Pulmonary Embolism: Survey of 800 CasesPLOS ONE, 2012
- Comparison of Clinical and Imaging Characteristics and Outcomes between Provoked and Unprovoked Acute Pulmonary Embolism in KoreansJournal of Korean Medical Science, 2012
- Pathophysiology of venous thrombosisThrombosis Research, 2009
- The Epidemiology of Venous ThromboembolismCirculation, 2003
- Venous Thromboembolism Epidemiology: Implications for Prevention and ManagementSeminars in Thrombosis and Hemostasis, 2002